Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-23

Clinical Trial Update: Anti-reflux Mucosectomy (ARMS) is a Useful Therapy for Refractory Gastroesophageal Reflux Disease (RGERD) [NA]

View source ↗

Summary

Clinical trial update suggests anti-reflux mucosectomy (ARMS) may be a useful therapy for refractory gastroesophageal reflux disease. The trial status is listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-reflux Mucosectomy (ARMS)

Snippet

Sponsor: Ruihua Shi | Conditions: Refractory Gastroesophageal Reflux Disease | NA | Status: UNKNOWN